nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—CYP19A1—esophageal cancer	0.874	1	CbGaD
Exemestane—Lymphoedema—Capecitabine—esophageal cancer	0.00302	0.0353	CcSEcCtD
Exemestane—Coronary artery disease—Cisplatin—esophageal cancer	0.00253	0.0296	CcSEcCtD
Exemestane—Joint stiffness—Capecitabine—esophageal cancer	0.00244	0.0285	CcSEcCtD
Exemestane—CYP19A1—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00233	0.0668	CbGpPWpGaD
Exemestane—Hepatitis cholestatic—Capecitabine—esophageal cancer	0.00183	0.0214	CcSEcCtD
Exemestane—Hoarseness—Capecitabine—esophageal cancer	0.00168	0.0196	CcSEcCtD
Exemestane—Opportunistic infection—Methotrexate—esophageal cancer	0.00136	0.0159	CcSEcCtD
Exemestane—Testolactone—CYP19A1—esophageal cancer	0.00131	0.259	CrCbGaD
Exemestane—Gastric ulcer—Capecitabine—esophageal cancer	0.00127	0.0148	CcSEcCtD
Exemestane—Deep vein thrombosis—Capecitabine—esophageal cancer	0.00121	0.0142	CcSEcCtD
Exemestane—Infection—Carboplatin—esophageal cancer	0.00121	0.0141	CcSEcCtD
Exemestane—Embolism—Capecitabine—esophageal cancer	0.00115	0.0134	CcSEcCtD
Exemestane—Pain—Carboplatin—esophageal cancer	0.00104	0.0122	CcSEcCtD
Exemestane—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.000997	0.0116	CcSEcCtD
Exemestane—Osteoporosis—Methotrexate—esophageal cancer	0.00098	0.0114	CcSEcCtD
Exemestane—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.000977	0.028	CbGpPWpGaD
Exemestane—Body temperature increased—Carboplatin—esophageal cancer	0.000963	0.0112	CcSEcCtD
Exemestane—Fracture—Methotrexate—esophageal cancer	0.000945	0.011	CcSEcCtD
Exemestane—Multiple fractures—Methotrexate—esophageal cancer	0.000945	0.011	CcSEcCtD
Exemestane—Neuropathy—Cisplatin—esophageal cancer	0.00094	0.011	CcSEcCtD
Exemestane—CYP19A1—Endogenous sterols—CYP1B1—esophageal cancer	0.000927	0.0266	CbGpPWpGaD
Exemestane—Myocardial ischaemia—Capecitabine—esophageal cancer	0.000918	0.0107	CcSEcCtD
Exemestane—Polyp—Methotrexate—esophageal cancer	0.000903	0.0105	CcSEcCtD
Exemestane—Deep vein thrombosis—Methotrexate—esophageal cancer	0.000903	0.0105	CcSEcCtD
Exemestane—Dysphonia—Capecitabine—esophageal cancer	0.000897	0.0105	CcSEcCtD
Exemestane—Embolism—Methotrexate—esophageal cancer	0.000856	0.00999	CcSEcCtD
Exemestane—Liver disorder—Methotrexate—esophageal cancer	0.000806	0.00941	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—PHB—esophageal cancer	0.000802	0.023	CbGpPWpGaD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.000773	0.0221	CbGpPWpGaD
Exemestane—Bone pain—Capecitabine—esophageal cancer	0.00077	0.00899	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00075	0.0215	CbGpPWpGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000745	0.0214	CbGpPWpGaD
Exemestane—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000742	0.00865	CcSEcCtD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00074	0.0212	CbGpPWpGaD
Exemestane—Pulmonary embolism—Capecitabine—esophageal cancer	0.000738	0.00861	CcSEcCtD
Exemestane—Influenza like illness—Capecitabine—esophageal cancer	0.000717	0.00836	CcSEcCtD
Exemestane—CYP19A1—Tryptophan metabolism—ALDH2—esophageal cancer	0.000703	0.0201	CbGpPWpGaD
Exemestane—Estrone—CYP1B1—esophageal cancer	0.000693	0.137	CrCbGaD
Exemestane—Neuropathy—Capecitabine—esophageal cancer	0.000693	0.00809	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00068	0.0195	CbGpPWpGaD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.000677	0.0194	CbGpPWpGaD
Exemestane—Neoplasm—Capecitabine—esophageal cancer	0.000667	0.00779	CcSEcCtD
Exemestane—Cramp muscle—Cisplatin—esophageal cancer	0.000654	0.00764	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000654	0.0187	CbGpPWpGaD
Exemestane—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.000625	0.0179	CbGpPWpGaD
Exemestane—Sweating increased—Cisplatin—esophageal cancer	0.000612	0.00714	CcSEcCtD
Exemestane—Bone disorder—Methotrexate—esophageal cancer	0.000608	0.0071	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000608	0.0174	CbGpPWpGaD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.0006	0.0172	CbGpPWpGaD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.000573	0.0164	CbGpPWpGaD
Exemestane—Hot flush—Capecitabine—esophageal cancer	0.000573	0.00668	CcSEcCtD
Exemestane—Increased appetite—Capecitabine—esophageal cancer	0.00057	0.00665	CcSEcCtD
Exemestane—Menopausal symptoms—Capecitabine—esophageal cancer	0.000568	0.00663	CcSEcCtD
Exemestane—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000552	0.00644	CcSEcCtD
Exemestane—Prednisolone—CYP2A6—esophageal cancer	0.000552	0.109	CrCbGaD
Exemestane—Arthritis—Capecitabine—esophageal cancer	0.000551	0.00643	CcSEcCtD
Exemestane—Pulmonary embolism—Methotrexate—esophageal cancer	0.000549	0.00641	CcSEcCtD
Exemestane—Myocardial infarction—Cisplatin—esophageal cancer	0.000549	0.00641	CcSEcCtD
Exemestane—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000549	0.00641	CcSEcCtD
Exemestane—Cardiac failure—Capecitabine—esophageal cancer	0.000549	0.00641	CcSEcCtD
Exemestane—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000547	0.00638	CcSEcCtD
Exemestane—Conjugated Estrogens—ABCC2—esophageal cancer	0.000542	0.107	CrCbGaD
Exemestane—Pain in extremity—Capecitabine—esophageal cancer	0.000536	0.00625	CcSEcCtD
Exemestane—Osteoarthritis—Capecitabine—esophageal cancer	0.000536	0.00625	CcSEcCtD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.000535	0.0153	CbGpPWpGaD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000534	0.0153	CbGpPWpGaD
Exemestane—CYP19A1—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000532	0.0153	CbGpPWpGaD
Exemestane—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00053	0.00618	CcSEcCtD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000527	0.0151	CbGpPWpGaD
Exemestane—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.000519	0.0149	CbGpPWpGaD
Exemestane—Neoplasm—Methotrexate—esophageal cancer	0.000497	0.0058	CcSEcCtD
Exemestane—Visual impairment—Cisplatin—esophageal cancer	0.000485	0.00565	CcSEcCtD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.000477	0.0137	CbGpPWpGaD
Exemestane—Cardiac disorder—Cisplatin—esophageal cancer	0.000467	0.00544	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000461	0.0132	CbGpPWpGaD
Exemestane—Immune system disorder—Cisplatin—esophageal cancer	0.000454	0.0053	CcSEcCtD
Exemestane—Angina pectoris—Capecitabine—esophageal cancer	0.000451	0.00526	CcSEcCtD
Exemestane—Sweating increased—Capecitabine—esophageal cancer	0.000451	0.00526	CcSEcCtD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.000449	0.0129	CbGpPWpGaD
Exemestane—Bronchitis—Capecitabine—esophageal cancer	0.000445	0.0052	CcSEcCtD
Exemestane—Alopecia—Cisplatin—esophageal cancer	0.000444	0.00518	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—esophageal cancer	0.000439	0.0126	CbGpPWpGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000433	0.0124	CbGpPWpGaD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000431	0.0123	CbGpPWpGaD
Exemestane—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00043	0.00502	CcSEcCtD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000425	0.0122	CbGpPWpGaD
Exemestane—Testosterone—CYP1B1—esophageal cancer	0.000421	0.0832	CrCbGaD
Exemestane—Weight increased—Capecitabine—esophageal cancer	0.000421	0.00492	CcSEcCtD
Exemestane—Visual disturbance—Methotrexate—esophageal cancer	0.000421	0.00491	CcSEcCtD
Exemestane—Muscle spasms—Cisplatin—esophageal cancer	0.000421	0.00491	CcSEcCtD
Exemestane—Depression—Capecitabine—esophageal cancer	0.000412	0.0048	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00041	0.0118	CbGpPWpGaD
Exemestane—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000407	0.00475	CcSEcCtD
Exemestane—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000407	0.00475	CcSEcCtD
Exemestane—Myocardial infarction—Capecitabine—esophageal cancer	0.000405	0.00472	CcSEcCtD
Exemestane—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000405	0.00472	CcSEcCtD
Exemestane—Urinary tract infection—Capecitabine—esophageal cancer	0.000401	0.00468	CcSEcCtD
Exemestane—Osteoarthritis—Methotrexate—esophageal cancer	0.000399	0.00465	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—ADH7—esophageal cancer	0.000396	0.0114	CbGpPWpGaD
Exemestane—Malaise—Cisplatin—esophageal cancer	0.000395	0.00461	CcSEcCtD
Exemestane—Leukopenia—Cisplatin—esophageal cancer	0.000392	0.00457	CcSEcCtD
Exemestane—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00039	0.00456	CcSEcCtD
Exemestane—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.000375	0.0108	CbGpPWpGaD
Exemestane—Myalgia—Cisplatin—esophageal cancer	0.000373	0.00435	CcSEcCtD
Exemestane—Haemoglobin—Capecitabine—esophageal cancer	0.000372	0.00435	CcSEcCtD
Exemestane—Rhinitis—Capecitabine—esophageal cancer	0.000372	0.00434	CcSEcCtD
Exemestane—Anxiety—Cisplatin—esophageal cancer	0.000371	0.00433	CcSEcCtD
Exemestane—Haemorrhage—Capecitabine—esophageal cancer	0.000371	0.00432	CcSEcCtD
Exemestane—Hepatitis—Capecitabine—esophageal cancer	0.000371	0.00432	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00037	0.00432	CcSEcCtD
Exemestane—Hypoaesthesia—Capecitabine—esophageal cancer	0.000369	0.0043	CcSEcCtD
Exemestane—Pharyngitis—Capecitabine—esophageal cancer	0.000368	0.00429	CcSEcCtD
Exemestane—Oedema peripheral—Capecitabine—esophageal cancer	0.000365	0.00426	CcSEcCtD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.000361	0.0103	CbGpPWpGaD
Exemestane—Oedema—Cisplatin—esophageal cancer	0.000357	0.00417	CcSEcCtD
Exemestane—Visual impairment—Capecitabine—esophageal cancer	0.000357	0.00417	CcSEcCtD
Exemestane—Infection—Cisplatin—esophageal cancer	0.000355	0.00414	CcSEcCtD
Exemestane—Erythema multiforme—Capecitabine—esophageal cancer	0.00035	0.00409	CcSEcCtD
Exemestane—Nervous system disorder—Cisplatin—esophageal cancer	0.00035	0.00409	CcSEcCtD
Exemestane—Thrombocytopenia—Cisplatin—esophageal cancer	0.00035	0.00408	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000349	0.01	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—ADH1B—esophageal cancer	0.000347	0.00995	CbGpPWpGaD
Exemestane—Skin disorder—Cisplatin—esophageal cancer	0.000347	0.00405	CcSEcCtD
Exemestane—Hyperhidrosis—Cisplatin—esophageal cancer	0.000345	0.00403	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000345	0.00988	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000345	0.00988	CbGpPWpGaD
Exemestane—Cardiac disorder—Capecitabine—esophageal cancer	0.000344	0.00401	CcSEcCtD
Exemestane—Anorexia—Cisplatin—esophageal cancer	0.00034	0.00397	CcSEcCtD
Exemestane—Immune system disorder—Capecitabine—esophageal cancer	0.000335	0.00391	CcSEcCtD
Exemestane—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.000329	0.00944	CbGpPWpGaD
Exemestane—Alopecia—Capecitabine—esophageal cancer	0.000327	0.00382	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000325	0.0038	CcSEcCtD
Exemestane—Mental disorder—Capecitabine—esophageal cancer	0.000325	0.00379	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP26A1—esophageal cancer	0.000323	0.00925	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000322	0.00924	CbGpPWpGaD
Exemestane—Paraesthesia—Cisplatin—esophageal cancer	0.000321	0.00374	CcSEcCtD
Exemestane—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00032	0.00374	CcSEcCtD
Exemestane—Dyspnoea—Cisplatin—esophageal cancer	0.000318	0.00372	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000318	0.00913	CbGpPWpGaD
Exemestane—Back pain—Capecitabine—esophageal cancer	0.000312	0.00364	CcSEcCtD
Exemestane—Decreased appetite—Cisplatin—esophageal cancer	0.000311	0.00362	CcSEcCtD
Exemestane—Muscle spasms—Capecitabine—esophageal cancer	0.00031	0.00362	CcSEcCtD
Exemestane—Testosterone—CYP19A1—esophageal cancer	0.000309	0.061	CrCbGaD
Exemestane—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000308	0.0036	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000307	0.0088	CbGpPWpGaD
Exemestane—Depression—Methotrexate—esophageal cancer	0.000306	0.00358	CcSEcCtD
Exemestane—Pain—Cisplatin—esophageal cancer	0.000305	0.00356	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTO1—esophageal cancer	0.0003	0.0086	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTO1—esophageal cancer	0.000296	0.00848	CbGpPWpGaD
Exemestane—Sweating—Methotrexate—esophageal cancer	0.000295	0.00344	CcSEcCtD
Exemestane—Feeling abnormal—Cisplatin—esophageal cancer	0.000294	0.00343	CcSEcCtD
Exemestane—Methylprednisolone—ABCB1—esophageal cancer	0.000291	0.0575	CrCbGaD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000291	0.00834	CbGpPWpGaD
Exemestane—Malaise—Capecitabine—esophageal cancer	0.000291	0.00339	CcSEcCtD
Exemestane—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000291	0.00339	CcSEcCtD
Exemestane—Leukopenia—Capecitabine—esophageal cancer	0.000289	0.00337	CcSEcCtD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.000284	0.00813	CbGpPWpGaD
Exemestane—Body temperature increased—Cisplatin—esophageal cancer	0.000282	0.00329	CcSEcCtD
Exemestane—Cough—Capecitabine—esophageal cancer	0.000282	0.00329	CcSEcCtD
Exemestane—Hypertension—Capecitabine—esophageal cancer	0.000279	0.00325	CcSEcCtD
Exemestane—Haemoglobin—Methotrexate—esophageal cancer	0.000277	0.00324	CcSEcCtD
Exemestane—Haemorrhage—Methotrexate—esophageal cancer	0.000276	0.00322	CcSEcCtD
Exemestane—Hepatitis—Methotrexate—esophageal cancer	0.000276	0.00322	CcSEcCtD
Exemestane—Arthralgia—Capecitabine—esophageal cancer	0.000275	0.00321	CcSEcCtD
Exemestane—Myalgia—Capecitabine—esophageal cancer	0.000275	0.00321	CcSEcCtD
Exemestane—Chest pain—Capecitabine—esophageal cancer	0.000275	0.00321	CcSEcCtD
Exemestane—Pharyngitis—Methotrexate—esophageal cancer	0.000274	0.0032	CcSEcCtD
Exemestane—Anxiety—Capecitabine—esophageal cancer	0.000274	0.00319	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000273	0.00318	CcSEcCtD
Exemestane—Visual impairment—Methotrexate—esophageal cancer	0.000266	0.0031	CcSEcCtD
Exemestane—Confusional state—Capecitabine—esophageal cancer	0.000265	0.0031	CcSEcCtD
Exemestane—Oedema—Capecitabine—esophageal cancer	0.000263	0.00307	CcSEcCtD
Exemestane—Hypersensitivity—Cisplatin—esophageal cancer	0.000263	0.00307	CcSEcCtD
Exemestane—Infection—Capecitabine—esophageal cancer	0.000262	0.00305	CcSEcCtD
Exemestane—Erythema multiforme—Methotrexate—esophageal cancer	0.000261	0.00304	CcSEcCtD
Exemestane—Nervous system disorder—Capecitabine—esophageal cancer	0.000258	0.00301	CcSEcCtD
Exemestane—Thrombocytopenia—Capecitabine—esophageal cancer	0.000258	0.00301	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000258	0.00739	CbGpPWpGaD
Exemestane—Asthenia—Cisplatin—esophageal cancer	0.000256	0.00299	CcSEcCtD
Exemestane—Cardiac disorder—Methotrexate—esophageal cancer	0.000256	0.00299	CcSEcCtD
Exemestane—Skin disorder—Capecitabine—esophageal cancer	0.000256	0.00298	CcSEcCtD
Exemestane—Hyperhidrosis—Capecitabine—esophageal cancer	0.000255	0.00297	CcSEcCtD
Exemestane—Anorexia—Capecitabine—esophageal cancer	0.000251	0.00293	CcSEcCtD
Exemestane—Immune system disorder—Methotrexate—esophageal cancer	0.000249	0.00291	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—ALDH2—esophageal cancer	0.000245	0.00701	CbGpPWpGaD
Exemestane—Diarrhoea—Cisplatin—esophageal cancer	0.000244	0.00285	CcSEcCtD
Exemestane—Alopecia—Methotrexate—esophageal cancer	0.000244	0.00284	CcSEcCtD
Exemestane—Mental disorder—Methotrexate—esophageal cancer	0.000242	0.00282	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00024	0.0028	CcSEcCtD
Exemestane—Insomnia—Capecitabine—esophageal cancer	0.000238	0.00278	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—esophageal cancer	0.000237	0.0068	CbGpPWpGaD
Exemestane—Paraesthesia—Capecitabine—esophageal cancer	0.000236	0.00276	CcSEcCtD
Exemestane—Dyspnoea—Capecitabine—esophageal cancer	0.000235	0.00274	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTT1—esophageal cancer	0.000233	0.00667	CbGpPWpGaD
Exemestane—Back pain—Methotrexate—esophageal cancer	0.000232	0.00271	CcSEcCtD
Exemestane—Dyspepsia—Capecitabine—esophageal cancer	0.000232	0.0027	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP2A6—esophageal cancer	0.00023	0.00659	CbGpPWpGaD
Exemestane—Decreased appetite—Capecitabine—esophageal cancer	0.000229	0.00267	CcSEcCtD
Exemestane—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000227	0.00265	CcSEcCtD
Exemestane—Vomiting—Cisplatin—esophageal cancer	0.000227	0.00265	CcSEcCtD
Exemestane—Fatigue—Capecitabine—esophageal cancer	0.000227	0.00265	CcSEcCtD
Exemestane—Rash—Cisplatin—esophageal cancer	0.000225	0.00263	CcSEcCtD
Exemestane—Constipation—Capecitabine—esophageal cancer	0.000225	0.00263	CcSEcCtD
Exemestane—Pain—Capecitabine—esophageal cancer	0.000225	0.00263	CcSEcCtD
Exemestane—Dermatitis—Cisplatin—esophageal cancer	0.000225	0.00263	CcSEcCtD
Exemestane—Prednisone—ABCB1—esophageal cancer	0.000223	0.044	CrCbGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000219	0.00627	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—PTGS1—esophageal cancer	0.000218	0.00625	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000218	0.00624	CbGpPWpGaD
Exemestane—Feeling abnormal—Capecitabine—esophageal cancer	0.000217	0.00253	CcSEcCtD
Exemestane—Malaise—Methotrexate—esophageal cancer	0.000217	0.00253	CcSEcCtD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000216	0.00619	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000215	0.00251	CcSEcCtD
Exemestane—Leukopenia—Methotrexate—esophageal cancer	0.000215	0.00251	CcSEcCtD
Exemestane—Nausea—Cisplatin—esophageal cancer	0.000212	0.00248	CcSEcCtD
Exemestane—Cough—Methotrexate—esophageal cancer	0.00021	0.00245	CcSEcCtD
Exemestane—Urticaria—Capecitabine—esophageal cancer	0.000209	0.00244	CcSEcCtD
Exemestane—Abdominal pain—Capecitabine—esophageal cancer	0.000208	0.00243	CcSEcCtD
Exemestane—Body temperature increased—Capecitabine—esophageal cancer	0.000208	0.00243	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—esophageal cancer	0.000206	0.00592	CbGpPWpGaD
Exemestane—Prednisolone—ABCB1—esophageal cancer	0.000205	0.0405	CrCbGaD
Exemestane—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000205	0.00588	CbGpPWpGaD
Exemestane—Chest pain—Methotrexate—esophageal cancer	0.000204	0.00239	CcSEcCtD
Exemestane—Myalgia—Methotrexate—esophageal cancer	0.000204	0.00239	CcSEcCtD
Exemestane—Arthralgia—Methotrexate—esophageal cancer	0.000204	0.00239	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000203	0.00237	CcSEcCtD
Exemestane—Conjugated Estrogens—ABCB1—esophageal cancer	0.000199	0.0394	CrCbGaD
Exemestane—Estrone—ABCB1—esophageal cancer	0.000199	0.0393	CrCbGaD
Exemestane—Confusional state—Methotrexate—esophageal cancer	0.000198	0.00231	CcSEcCtD
Exemestane—Infection—Methotrexate—esophageal cancer	0.000195	0.00227	CcSEcCtD
Exemestane—Hypersensitivity—Capecitabine—esophageal cancer	0.000194	0.00226	CcSEcCtD
Exemestane—Nervous system disorder—Methotrexate—esophageal cancer	0.000192	0.00224	CcSEcCtD
Exemestane—Thrombocytopenia—Methotrexate—esophageal cancer	0.000192	0.00224	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000191	0.00547	CbGpPWpGaD
Exemestane—Skin disorder—Methotrexate—esophageal cancer	0.00019	0.00222	CcSEcCtD
Exemestane—Hyperhidrosis—Methotrexate—esophageal cancer	0.000189	0.00221	CcSEcCtD
Exemestane—Asthenia—Capecitabine—esophageal cancer	0.000189	0.0022	CcSEcCtD
Exemestane—Anorexia—Methotrexate—esophageal cancer	0.000187	0.00218	CcSEcCtD
Exemestane—Pruritus—Capecitabine—esophageal cancer	0.000186	0.00217	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP1B1—esophageal cancer	0.000185	0.00531	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000183	0.00524	CbGpPWpGaD
Exemestane—Diarrhoea—Capecitabine—esophageal cancer	0.00018	0.0021	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—esophageal cancer	0.000179	0.00513	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000179	0.00513	CbGpPWpGaD
Exemestane—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000179	0.00208	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000177	0.00508	CbGpPWpGaD
Exemestane—Insomnia—Methotrexate—esophageal cancer	0.000177	0.00207	CcSEcCtD
Exemestane—Paraesthesia—Methotrexate—esophageal cancer	0.000176	0.00205	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ABL1—esophageal cancer	0.000175	0.00502	CbGpPWpGaD
Exemestane—Dyspnoea—Methotrexate—esophageal cancer	0.000175	0.00204	CcSEcCtD
Exemestane—Dizziness—Capecitabine—esophageal cancer	0.000174	0.00203	CcSEcCtD
Exemestane—Dyspepsia—Methotrexate—esophageal cancer	0.000173	0.00201	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000171	0.0049	CbGpPWpGaD
Exemestane—Decreased appetite—Methotrexate—esophageal cancer	0.00017	0.00199	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—esophageal cancer	0.000169	0.00486	CbGpPWpGaD
Exemestane—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000169	0.00197	CcSEcCtD
Exemestane—Fatigue—Methotrexate—esophageal cancer	0.000169	0.00197	CcSEcCtD
Exemestane—Pain—Methotrexate—esophageal cancer	0.000168	0.00196	CcSEcCtD
Exemestane—Vomiting—Capecitabine—esophageal cancer	0.000167	0.00195	CcSEcCtD
Exemestane—Rash—Capecitabine—esophageal cancer	0.000166	0.00194	CcSEcCtD
Exemestane—Dermatitis—Capecitabine—esophageal cancer	0.000166	0.00194	CcSEcCtD
Exemestane—Headache—Capecitabine—esophageal cancer	0.000165	0.00192	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000163	0.00467	CbGpPWpGaD
Exemestane—Feeling abnormal—Methotrexate—esophageal cancer	0.000162	0.00188	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.00016	0.0046	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00016	0.00187	CcSEcCtD
Exemestane—Nausea—Capecitabine—esophageal cancer	0.000156	0.00183	CcSEcCtD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000156	0.00447	CbGpPWpGaD
Exemestane—Urticaria—Methotrexate—esophageal cancer	0.000156	0.00182	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000155	0.00445	CbGpPWpGaD
Exemestane—Abdominal pain—Methotrexate—esophageal cancer	0.000155	0.00181	CcSEcCtD
Exemestane—Body temperature increased—Methotrexate—esophageal cancer	0.000155	0.00181	CcSEcCtD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000154	0.00441	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000146	0.00419	CbGpPWpGaD
Exemestane—Hypersensitivity—Methotrexate—esophageal cancer	0.000144	0.00169	CcSEcCtD
Exemestane—Asthenia—Methotrexate—esophageal cancer	0.000141	0.00164	CcSEcCtD
Exemestane—Pruritus—Methotrexate—esophageal cancer	0.000139	0.00162	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000134	0.00385	CbGpPWpGaD
Exemestane—Diarrhoea—Methotrexate—esophageal cancer	0.000134	0.00156	CcSEcCtD
Exemestane—Dizziness—Methotrexate—esophageal cancer	0.00013	0.00151	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000126	0.00362	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000126	0.0036	CbGpPWpGaD
Exemestane—Vomiting—Methotrexate—esophageal cancer	0.000125	0.00145	CcSEcCtD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000124	0.00355	CbGpPWpGaD
Exemestane—Rash—Methotrexate—esophageal cancer	0.000124	0.00144	CcSEcCtD
Exemestane—Dermatitis—Methotrexate—esophageal cancer	0.000123	0.00144	CcSEcCtD
Exemestane—Headache—Methotrexate—esophageal cancer	0.000123	0.00143	CcSEcCtD
Exemestane—Testosterone—ABCB1—esophageal cancer	0.000121	0.0239	CrCbGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000121	0.00346	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00012	0.00343	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000118	0.00339	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000117	0.00334	CbGpPWpGaD
Exemestane—Nausea—Methotrexate—esophageal cancer	0.000116	0.00136	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000116	0.00331	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000114	0.00326	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000113	0.00323	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000105	0.00302	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000102	0.00292	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000101	0.0029	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	9.76e-05	0.0028	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	9.58e-05	0.00275	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	9.42e-05	0.0027	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC52A3—esophageal cancer	9.37e-05	0.00269	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—BLVRB—esophageal cancer	9.37e-05	0.00269	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	9.29e-05	0.00266	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	8.76e-05	0.00251	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	8.64e-05	0.00248	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	8.38e-05	0.0024	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	8.37e-05	0.0024	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CA1—esophageal cancer	7.96e-05	0.00228	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC10A2—esophageal cancer	7.96e-05	0.00228	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	7.71e-05	0.00221	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CA2—esophageal cancer	7.28e-05	0.00209	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	7.14e-05	0.00205	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	7.12e-05	0.00204	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	6.79e-05	0.00195	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADH7—esophageal cancer	6.77e-05	0.00194	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PLCE1—esophageal cancer	6.77e-05	0.00194	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	6.72e-05	0.00193	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	6.71e-05	0.00192	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	6.57e-05	0.00188	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	6.36e-05	0.00182	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADH1B—esophageal cancer	5.94e-05	0.0017	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TYMP—esophageal cancer	5.67e-05	0.00163	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP26A1—esophageal cancer	5.52e-05	0.00158	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	5.52e-05	0.00158	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	5.41e-05	0.00155	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALOX15—esophageal cancer	5.38e-05	0.00154	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	5.34e-05	0.00153	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTO1—esophageal cancer	5.13e-05	0.00147	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TPI1—esophageal cancer	5.13e-05	0.00147	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	5.09e-05	0.00146	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	5.02e-05	0.00144	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALDOB—esophageal cancer	4.92e-05	0.00141	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GAPDH—esophageal cancer	4.74e-05	0.00136	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CRABP1—esophageal cancer	4.69e-05	0.00135	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GNG7—esophageal cancer	4.46e-05	0.00128	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALDH2—esophageal cancer	4.18e-05	0.0012	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTT1—esophageal cancer	3.98e-05	0.00114	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2A6—esophageal cancer	3.93e-05	0.00113	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.92e-05	0.00112	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTGS1—esophageal cancer	3.73e-05	0.00107	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ENO1—esophageal cancer	3.73e-05	0.00107	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PSME2—esophageal cancer	3.67e-05	0.00105	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PSME1—esophageal cancer	3.67e-05	0.00105	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.21e-05	0.00092	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1B1—esophageal cancer	3.17e-05	0.000909	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.73e-05	0.000784	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.73e-05	0.000784	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMOX1—esophageal cancer	2.72e-05	0.00078	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.67e-05	0.000765	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCB1—esophageal cancer	2.61e-05	0.000748	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.32e-05	0.000666	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CA1—esophageal cancer	2.32e-05	0.000666	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CA2—esophageal cancer	2.13e-05	0.000609	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.98e-05	0.000567	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADH7—esophageal cancer	1.98e-05	0.000567	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.97e-05	0.000566	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CREBBP—esophageal cancer	1.74e-05	0.0005	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.73e-05	0.000497	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TYMP—esophageal cancer	1.66e-05	0.000475	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.61e-05	0.000462	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.57e-05	0.00045	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NOS3—esophageal cancer	1.56e-05	0.000448	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TPI1—esophageal cancer	1.5e-05	0.000429	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.5e-05	0.000429	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.44e-05	0.000412	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTGS2—esophageal cancer	1.43e-05	0.00041	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.38e-05	0.000396	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.37e-05	0.000393	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GNG7—esophageal cancer	1.3e-05	0.000374	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.22e-05	0.00035	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—EP300—esophageal cancer	1.19e-05	0.000341	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.16e-05	0.000333	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.15e-05	0.000329	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.09e-05	0.000312	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ENO1—esophageal cancer	1.09e-05	0.000312	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PSME1—esophageal cancer	1.07e-05	0.000307	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PSME2—esophageal cancer	1.07e-05	0.000307	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.25e-06	0.000265	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CA—esophageal cancer	8.79e-06	0.000252	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.7e-06	0.000249	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.94e-06	0.000228	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.62e-06	0.000218	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.09e-06	0.000146	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NOS3—esophageal cancer	4.56e-06	0.000131	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.17e-06	0.00012	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—EP300—esophageal cancer	3.47e-06	9.94e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.57e-06	7.35e-05	CbGpPWpGaD
